大阳城集团娱乐网址(中国)在线官网APP Green下载

Dr. Li Feng

Chairman of the Board and General Manager

Dr. Li is responsible for the overall management, business strategies, regulatory approvals and commercial suitability and sustainability of products of the Group. Dr. Li has over 19 years of experience in the biopharmaceutical industry, and he was the former engineer in charge of the research and development department in Genentech, a former senior scientist in Amgen and a former engineer at Tanox.

Mr. Liang Jinjin

Chief Medical Officer and Deputy General Manager

Mr. Liang is responsible for clinical development, operation and management. Mr.Liang has over 13 years of experience in clinical development in China and the United States with strong expertise in medical sciences and biostatistics. He was a former vice president and the general manager for ICON Greater China, a former vice president and the general manager for WuXi Clinical, and a former senior director and general manager for Quintiles Dalian Center of Excellence.

Dr. Liu Huifang

Deputy General Manager
(Translational Medicine and Regulatory Affairs)

Dr. Liu is responsible for pharmacology, translational medicine and regulatory affairs. Dr. Liu has over 20 years of experience in the biopharmaceutical industry, and she was a former scientist and senior scientist at Gilead Sciences, Genentech and Tanox.

Dr. Li Jiangmei

Deputy General Manager
(Innovation Technology Platform)

Dr. Li is responsible for the preliminary research and development of Innovation Technology Platform. Dr. Li has over 13 years of experience in the biopharmaceutical industry. She was a former associate professor for National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences and a former associate professor for  Shanghai Institute for Advanced Immunochemical Studies (SIAIS), ShanghaiTech University.

Dr. Li Feng

Chairman of the Board and General Manager

Mr. Liang Jinjin

Chief Medical Officer and Deputy General Manager

Dr. Liu Huifang

Deputy General Manager
(Translational Medicine and Regulatory Affairs)

Dr. Li Jiangmei

Deputy General Manager
(Innovation Technology Platform)